FDA Breakthrough Device Designation for blood infection test

FDA Breakthrough Device Designation for blood infection test:

The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.

While the US regulator first launched the similar Breakthrough Therapy Designation for innovative medicines six years ago, the similar fast-track for devices was formalised in late 2017.